Yajie Xiao

发表

Treatment beyond progression with chemo-immunotherapy in an advanced esophageal squamous cell carcinoma patient: a case report

Chao Sun, P. Peng, Yajie Xiao, 2021, Translational cancer research.

BUB1 Is Identified as a Potential Therapeutic Target for Pancreatic Cancer Treatment

Yajie Xiao, Zhikun Zhao, Dongfang Wu, 2022, Frontiers in Public Health.

Exploring the Interplay between Metabolism and Tumor Microenvironment Based on Four Major Metabolism Pathways in Colon Adenocarcinoma

Guangmei Zhang, Yajie Xiao, Zhikun Zhao, 2022, Journal of oncology.

In-depth genomic characterization of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients.

Jun Liu, Yajie Xiao, Zhikun Zhao, 2021, Journal of Clinical Oncology.

Identification of APC Mutation as a Potential Predictor for Immunotherapy in Colorectal Cancer

Wei Wang, Weiqi Wang, Hanqing Lin, 2022, Journal of oncology.

Identification of a novel RMST-ALK rearrangement in advanced lung adenocarcinoma and durable response to ceritinib: A case report

B. Chen, Geng-peng Lin, Yajie Xiao, 2022, Frontiers in Oncology.

Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma

Yajie Xiao, Long Xu, Xiaoli Cui, 2022, Frontiers in Genetics.

Comprehensive Analysis of Histone Modifications in Hepatocellular Carcinoma Reveals Different Subtypes and Key Prognostic Models

H. Mu, Yajie Xiao, Zhikun Zhao, 2022, Journal of oncology.

The mechanism of lncRNAs in the crosstalk between epithelial-mesenchymal transition and tumor microenvironment for early colon adenocarcinoma based on molecular subtyping

Yajie Xiao, Zhikun Zhao, Dongfang Wu, 2022, Frontiers in Genetics.

Durable Response to Immunotherapy With Antiangiogenic Drug in Large-Cell Lung Carcinoma With Multiple Fulminant Postoperative Metastases: A Case Report

Chao Sun, Liping Zhang, Yuwei Cao, 2021, Frontiers in Oncology.

Identification of Clonal Neoantigens Derived From Driver Mutations in an EGFR-Mutated Lung Cancer Patient Benefitting From Anti-PD-1

Yue Hu, Yajie Xiao, Zhikun Zhao, 2020, Frontiers in Immunology.

Genomic profiles and transcriptomic microenvironments in 2 patients with synchronous lung adenocarcinoma and lung squamous cell carcinoma: a case report

Longyun Chen, Q. Tan, Yajie Xiao, 2020, BMC Medical Genomics.

Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients

Yajie Xiao, Zhikun Zhao, Dongfang Wu, 2022, Cancer cell international.

Good Tumor Response to Chemoradioimmunotherapy in dMMR/MSI-H Advanced Colorectal Cancer: A Case Series

Yuan-hong Gao, Rong Zhang, Hanqing Lin, 2021, Frontiers in Immunology.

The Potential Bioactive Components of Nine TCM Prescriptions Against COVID-19 in Lung Cancer Were Explored Based on Network Pharmacology and Molecular Docking

Yu Cao, F. Chen, Xun Zhang, 2022, Frontiers in Medicine.

Case Report: Therapeutic Response to Chemo-Immunotherapy in an Advanced Large Cell Lung Carcinoma Patient With Low Values of Multiple Predictive Biomarkers

Guihua Wang, Hanqing Lin, Lin Wu, 2021, Frontiers in Immunology.

Investigations of sequencing data and sample type on HLA class Ia typing with different computational tools

Yajie Xiao, Jian Yi, Longyun Chen, 2020, Briefings Bioinform..

Correlation between Tumor Microenvironment and Immune Subtypes Based on CD8 T Cells Enhancing Personalized Therapy of Gastric Cancer

Hai-feng Yang, Yajie Xiao, Dongfang Wu, 2022, Journal of oncology.

Identification and Validation of 7-lncRNA Signature of Epigenetic Disorders by Comprehensive Epigenetic Analysis

Yu Deng, Peng Cao, Yajie Xiao, 2022, Disease markers.

Expression Patterns of Glycosylation Regulators Define Tumor Microenvironment and Immunotherapy in Gastric Cancer

Qijun Zheng, Yajie Xiao, Kaibin Huang, 2022, Frontiers in Cell and Developmental Biology.

Transcription factor NFIC functions as a tumor suppressor in lung squamous cell carcinoma progression by modulating lncRNA CASC2

Chao Sun, Yajie Xiao, Zhilin Luo, 2022, Cell cycle.

Molecular characteristics of multiple primary pulmonary nodules under a three-dimensional reconstruction model and relevant multi-omics analyses: a case report

Yajie Xiao, Zhikun Zhao, Dongfang Wu, 2023, Frontiers in Oncology.

Case Report: Durable Complete Response After Combined Immunotherapy Following Resection of Primary Tumor in a Gallbladder Cancer Patient With Distant Metastatic Lymph Nodes of Favorable Immune-Microenvironment

Chao Sun, Yajie Xiao, Zhikun Zhao, 2022, Frontiers in Immunology.

Complete response to first-line osimertinib monotherapy in a complex epidermal growth factor receptor mutant (L833V/H835L) lung adenocarcinoma patient: a case report.

Yajie Xiao, Zhilin Luo, Tianhu Wang, 2023, Anti-Cancer Drugs.

Genomic profiles and transcriptomic microenvironments in 2 patients with synchronous lung adenocarcinoma and lung squamous cell carcinoma: a case report

Longyun Chen, Q. Tan, Yajie Xiao, 2020, BMC Medical Genomics.

Understanding the Critical Role of Glycolysis-Related lncRNAs in Lung Adenocarcinoma Based on Three Molecular Subtypes

Yu Deng, Peng Cao, Yajie Xiao, 2022, BioMed research international.

Genomic and Immunological Characterization of Pyroptosis in Lung Adenocarcinoma

Yajie Xiao, Zhikun Zhao, Dongfang Wu, 2022, Journal of oncology.

A Novel Intergenic Region Between KLHL31 and LRRC1-ALK Exon 20 Fusion Variant in Advanced Lung Adenocarcinoma and its Remarkable Response to ALK Inhibitor.

Qianwen Li, Yajie Xiao, Dongfang Wu, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.